Early-Phase Cancer Clinical Trials & Investigational Treatments

Early-Phase Cancer Clinical Trials & Investigational Treatments

Clinical trials offer our patients with advanced cancer early access to new treatments that may improve care and quality of life.

On this page

Why choose UCSF Health for phase 1 cancer clinical trials?

UCSF Health is home to one of the largest early-phase (phase 1) cancer clinical trial programs on the West Coast. As an internationally recognized research center, we have the resources and capabilities to conduct studies not available at many other institutions.

Our physician-scientists investigate the newest treatments for many types of cancer, including new medications or innovative combination therapies. Clinical trials may improve outcomes and quality of life for people living with cancer – and our patients are often the first to benefit from these breakthroughs.

What are phase 1 clinical trials?

Clinical trials evaluate the safety and effectiveness of new tests and treatments. Treatments go through several phases of clinical trials before they're approved by the FDA and available for widespread use. An early-phase clinical trial, or phase 1 trial, is the first time a treatment is tested outside a laboratory in a small group of people.

Phase 1 trials for cancer are typically for advanced (metastatic) cancer, which is cancer that has spread to other parts of the body. Phase 2, 3 and 4 trials may be appropriate for people with all stages of cancer.

A phase 1 trial for a new treatment helps us determine its:

  • Safety and potential side effects

  • Most effective dose

  • Best delivery method

Learn more about all phases of clinical trials at UCSF Health.

Benefits of early-phase cancer clinical trials

Early-phase trials have several benefits, including:

  • Access to leading-edge treatments not available elsewhere

  • An extra level of care with attentive monitoring from the clinical trial team, in addition to your regular care team

  • More treatment options if you haven't responded to standard therapies

  • The opportunity to contribute to important research that can help others in the future

Providers

Excellence in patient care

Our expertise has earned top rankings from U.S. News & World Report.

Related services

FAQs about early-phase cancer clinical trials

If you’re considering an early-phase clinical trial, our team is here to answer your questions. Talk to your care team to decide if an investigational study is right for you.

Accreditations & memberships

  • National Cancer Institute

    National Cancer Institute

    The National Cancer Institute has designated UCSF Health a comprehensive cancer center, its highest ranking. This designation is awarded to centers that demonstrate scientific excellence and the ability to conduct cancer research across many disciplines.
  • Commission on Cancer

    Commission on Cancer

    UCSF Health's cancer programs have been accredited by the American College of Surgeons' Commission on Cancer (CoC) since 1933. The CoC is a consortium of groups dedicated to improving cancer patients' survival and quality of life via research, education and better medical care.
  • National Comprehensive Cancer Network

    National Comprehensive Cancer Network

    UCSF is a member of the National Comprehensive Cancer Network, an alliance of the world's top cancer centers. The network brings together leaders in treatment and research to improve the quality, effectiveness and efficiency of cancer care.

Find cancer clinical trials

Cancer clinical trials for children

We offer a range of early-phase clinical trials for children, investigating new therapies for brain tumors, leukemia and other childhood cancers.